|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 14/435 |
| (11) | Patento numeris | 3319982 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16738403.1 |
| Europos patento paraiškos padavimo data | 2016-07-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-05-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-02-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2016/066299 |
| Data | 2016-07-08 |
| (87) | Numeris | WO 2017/009236 |
| Data | 2017-01-19 |
| (30) | Numeris | Data | Šalis |
| 15306141 | 2015-07-10 | EP |
| (72) |
BOSSART, Martin, DE
EVERS, Andreas, DE
HAACK, Torsten, DE
LORENZ, Katrin, DE
KADEREIT, Dieter, DE
WAGNER, Michael, DE
HENKEL, Bernd, DE
|
| (73) |
SANOFI,
54, rue La Boétie, 75008 Paris,
FR
|
| (54) | NEW EXENDIN-4 DERIVATIVES AS SELECTIVE PEPTIDIC DUAL GLP-1 / GLUCAGON RECEPTOR AGONISTS |
| NEW EXENDIN-4 DERIVATIVES AS SELECTIVE PEPTIDIC DUAL GLP-1 / GLUCAGON RECEPTOR AGONISTS |